GO:0015055 secretin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015055 (secretin receptor activity) is a molecular function defined as combining with secretin to initiate a change in cell activity.
• The secretin receptor (SCTR) is a class B G protein-coupled receptor that primarily signals through Gs-mediated cAMP production.
• Secretin receptor activity has been characterized in gastric glands, gastrinomas, and pancreatic tissues, where it regulates secretion and cell proliferation [1,5].
• Secretin receptor-deficient mice show altered circadian rhythms and robust food anticipatory activity, linking the receptor to metabolic and behavioral regulation [2,4].
• Pharmacological studies have identified small-molecule agonists and peptide analogs that modulate secretin receptor activity, offering therapeutic potential [3,7].
• Research on secretin receptor activity employs binding assays, cAMP measurements, mutagenesis, and CRISPR-based models to dissect its signaling and physiology [6,8].
Description
Secretin receptor activity (GO:0015055) is a molecular function that mediates the cellular response to the peptide hormone secretin. This activity is essential for the regulation of secretion, digestion, and energy homeostasis, and it is primarily attributed to the secretin receptor (SCTR), a class B G protein-coupled receptor (GPCR). The receptor is expressed in various tissues, including the pancreas, stomach, and brain, where it couples to Gs proteins to activate adenylyl cyclase and increase intracellular cAMP levels [1,6]. Understanding secretin receptor activity is crucial for elucidating gastrointestinal physiology and for developing therapeutics targeting metabolic and neuroendocrine disorders [3,5]. Dysregulation of secretin receptor activity has been implicated in gastrinomas, where receptor expression correlates with clinical features and provocative test results. Moreover, secretin receptor-deficient mice exhibit altered circadian rhythms and food anticipatory activity, highlighting its role beyond the gut [2,4]. The receptor's structure and ligand-binding mechanisms have been probed through mutagenesis and structure-activity relationship studies, revealing key determinants of agonist efficacy [7,8]. These findings underscore the importance of secretin receptor activity as a research focus in endocrinology and neurobiology. This article provides a comprehensive overview of GO:0015055, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental models. By integrating authoritative QuickGO data with verified PubMed literature, we aim to support researchers in designing robust studies on secretin receptor signaling.
secretin receptor activity At A Glance
| GO ID | GO:0015055 |
|---|---|
| GO term | secretin receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to secretin and initiating intracellular signaling, primarily via cAMP |
| Receptor family | Class B G protein-coupled receptor (GPCR) |
| Primary ligand | Secretin (SCT) |
| Major signaling pathway | Gs-mediated adenylyl cyclase activation and cAMP production |
| Tissue distribution | Pancreas, stomach, brain, and other tissues |
What Is GO:0015055?
Secretin receptor activity (GO:0015055) is defined as the molecular function of combining with the hormone secretin to initiate a change in cell activity. This activity is mediated by the secretin receptor, which upon binding to secretin undergoes conformational changes that activate intracellular signaling cascades, typically through G protein coupling and second messenger production [1,6].
Why Is secretin receptor activity Important in Cell Biology?
Secretin receptor activity is fundamental to gastrointestinal and neuroendocrine physiology, regulating secretion, motility, and energy balance. Its dysfunction is associated with gastrinomas and metabolic disorders, making it a target for diagnostic and therapeutic interventions [5,3].
• Regulates pancreatic bicarbonate secretion and digestive enzyme release.
• Modulates gastric acid secretion and mucosal protection.
• Influences circadian rhythms and food anticipatory behavior [2,4].
• Implicated in gastrinoma pathophysiology and clinical test outcomes.
• Serves as a target for small-molecule agonists with therapeutic potential.
• Provides a model for class B GPCR structure-function studies [6,8].
• Plays a role in energy homeostasis and metabolic regulation.
• Enables research on receptor mutagenesis and ligand docking.
What Happens During secretin receptor activity?
Ligand Binding and Receptor Activation
In simple terms: Secretin binds to its receptor, causing the receptor to change shape and become active.
Secretin, a 27-amino-acid peptide hormone, binds to the extracellular domain of the secretin receptor, a class B GPCR. This interaction triggers conformational changes that propagate through the transmembrane domains, leading to G protein activation [6,8]. Mutagenesis studies have identified key residues in the receptor's N-terminal domain that are critical for secretin docking and agonist efficacy.
G Protein Coupling and cAMP Production
In simple terms: The activated receptor turns on a G protein, which then boosts cAMP levels inside the cell.
The secretin receptor primarily couples to the stimulatory G protein (Gs), which activates adenylyl cyclase to convert ATP into cyclic AMP (cAMP). Elevated cAMP then activates protein kinase A (PKA) and other effectors, leading to cellular responses such as secretion and gene expression changes [1,6]. This signaling cascade has been demonstrated in rat gastric glands, where secretin binding increases cAMP generation.
Receptor Desensitization and Internalization
In simple terms: After signaling, the receptor is turned off and brought inside the cell to prevent overstimulation.
Following prolonged agonist exposure, the secretin receptor undergoes phosphorylation by G protein-coupled receptor kinases (GRKs), leading to β-arrestin recruitment and receptor internalization. This process attenuates cAMP signaling and resensitizes the cell for subsequent stimulation [6,8]. The molecular determinants of desensitization have been explored through receptor mutagenesis and pharmacological studies.
Tissue-Specific Signaling Outcomes
In simple terms: The same receptor can cause different effects depending on the tissue it is in.
In pancreatic acinar cells, secretin receptor activity stimulates bicarbonate-rich fluid secretion, while in gastric glands it modulates acid and mucus secretion. In the brain, secretin receptor signaling influences circadian rhythms and food anticipatory activity, as shown in receptor-deficient mice [2,4]. These tissue-specific outcomes are mediated by differential expression of downstream effectors and interacting proteins.
Key Genes Involved in GO:0015055 secretin receptor activity
The following genes and proteins are central to secretin receptor activity and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCTR | Encodes the secretin receptor, a class B GPCR that binds secretin and activates Gs/cAMP signaling | Primary target for mutagenesis, binding assays, and knockout studies [1,6] |
| SCT | Encodes the secretin hormone, the endogenous ligand for the receptor | Used in agonist studies and structure-activity relationship analyses |
| GNAS | Encodes the Gs alpha subunit that couples to the secretin receptor | Key mediator of cAMP production; mutations affect signaling |
| ADCY1 | Encodes adenylyl cyclase 1, an enzyme that produces cAMP | Downstream effector; potential target for modulating receptor activity |
| PRKACA | Encodes the catalytic subunit of PKA, a major downstream kinase | Mediates phosphorylation events following cAMP elevation |
| ARRB1 | Encodes β-arrestin 1, involved in receptor desensitization and internalization | Regulates receptor trafficking and signaling duration |
| ARRB2 | Encodes β-arrestin 2, another arrestin involved in GPCR regulation | Modulates secretin receptor desensitization |
| GRK2 | Encodes a G protein-coupled receptor kinase that phosphorylates activated receptors | Involved in homologous desensitization of the secretin receptor |
| GRK3 | Encodes another GRK isoform that can phosphorylate GPCRs | Potential regulator of secretin receptor phosphorylation |
| CREB1 | Encodes cAMP response element-binding protein, a transcription factor activated by PKA | Mediates gene expression changes downstream of secretin receptor activity |
| CFTR | Encodes the cystic fibrosis transmembrane conductance regulator, a chloride channel | Effector in secretin-stimulated bicarbonate secretion in pancreas |
| SLC26A6 | Encodes an anion exchanger involved in bicarbonate secretion | Downstream target in secretin-responsive tissues |
| VIPR1 | Encodes a related class B GPCR for VIP, which can heterodimerize with SCTR | Modulates secretin receptor signaling through receptor cross-talk |
| GCG | Encodes glucagon, a hormone related to secretin | Used in comparative studies of class B GPCR activation |
| GIPR | Encodes the glucose-dependent insulinotropic polypeptide receptor | Provides structural and functional comparisons for class B GPCRs |
| GLP1R | Encodes the glucagon-like peptide-1 receptor | Model for understanding secretin receptor pharmacology |
| PTH1R | Encodes the parathyroid hormone 1 receptor | Another class B GPCR used in comparative signaling studies |
How Is secretin receptor activity Regulated?
Secretin receptor activity is regulated at multiple levels. Receptor expression can be modulated by hormonal and metabolic cues, as seen in gastrinomas where receptor levels correlate with clinical features. At the protein level, agonist-induced phosphorylation by GRKs and subsequent β-arrestin binding lead to desensitization and internalization, dampening cAMP signaling [6,8]. Additionally, receptor activity can be influenced by heterodimerization with other class B GPCRs, such as VIPR1, which may alter ligand binding and signaling efficacy. These regulatory mechanisms ensure appropriate cellular responses to secretin and prevent overstimulation.
secretin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCTR | Gastrinoma, neuroendocrine tumors | SCTR knockout or overexpression in gastrinoma cell lines |
| SCTR | Circadian rhythm disruption, metabolic syndrome | SCTR knockout mice for behavioral and metabolic studies [2,4] |
| SCTR | Pancreatic insufficiency | Conditional SCTR knockout in pancreatic acinar cells |
| GNAS | McCune-Albright syndrome (ectopic cAMP signaling) | Point mutation of GNAS in secretin-responsive cells |
| CFTR | Cystic fibrosis (bicarbonate secretion defect) | CFTR knockout in pancreatic ductal cells |
Gastrinomas and Neuroendocrine Tumors
Secretin receptor expression is frequently detected in gastrinomas, where it correlates with clinical and tumoral features. The secretin provocative test, which relies on secretin receptor activity, is used diagnostically; aberrant receptor signaling may contribute to excessive gastrin secretion and tumor growth. Targeting secretin receptor activity could offer therapeutic benefits in these tumors.
Metabolic and Circadian Disorders
Secretin receptor-deficient mice exhibit altered circadian rhythms in wheel-running activity and robust food anticipatory activity, indicating a role for the receptor in regulating biological clocks and energy balance [2,4]. These findings suggest that dysregulated secretin receptor activity may contribute to metabolic syndrome and sleep disorders.
Gastrointestinal Secretory Disorders
Impaired secretin receptor activity can lead to defective pancreatic bicarbonate secretion, as seen in conditions like chronic pancreatitis. The receptor's role in gastric gland cAMP generation also implicates it in acid-peptic disorders. Modulating receptor activity may help restore secretory function.
From secretin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SCTR mediate secretin-induced cAMP production? | SCTR knockout cell line (e.g., CRISPR-Cas9) |
| What are the structural determinants of secretin binding? | Point mutations in SCTR extracellular domain |
| How does SCTR signaling affect circadian behavior? | SCTR knockout mice [2,4] |
| Can a tagged SCTR be used to track receptor trafficking? | Knock-in of fluorescent protein tag at SCTR locus |
| Does overexpression of SCTR enhance secretin responsiveness? | SCTR overexpression in heterologous cells |
| What is the role of SCTR in gastrinoma growth? | SCTR knockdown or knockout in gastrinoma cell lines |
How to Study the secretin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Receptor affinity and density | Characterizing secretin receptor in tissues |
| cAMP assay | Intracellular cAMP levels | Assessing agonist-induced signaling [1,6] |
| Site-directed mutagenesis | Functional impact of specific residues | Mapping ligand-binding pocket |
| CRISPR-Cas9 knockout | Loss-of-function phenotypes | Studying receptor physiology in mice [2,4] |
| Fluorescence microscopy | Receptor localization and trafficking | Tracking tagged SCTR internalization |
| Structure-activity relationship (SAR) | Agonist potency and efficacy | Developing small-molecule agonists |
| Secretin provocative test | Clinical response to secretin | Diagnosing gastrinoma |
| RNA-seq | Transcriptional changes | Identifying downstream targets of receptor activation |
Receptor Binding Assays
Radioligand binding assays using 125I-secretin are used to measure receptor affinity and density in tissues or cells. These assays have been applied to rat gastric glands to characterize secretin receptor activity and pharmacology. Competitive binding with agonists or antagonists can reveal structure-activity relationships.
cAMP Measurement
Intracellular cAMP levels are quantified using radioimmunoassays, ELISA, or luminescent biosensors. Secretin-stimulated cAMP generation is a hallmark of receptor activity and has been measured in gastric glands and transfected cells [1,6]. This method is essential for assessing agonist efficacy and potency.
Mutagenesis and Structure-Function Studies
Site-directed mutagenesis of the secretin receptor is employed to identify residues critical for ligand binding and G protein coupling. Complementary mutagenesis of secretin has elucidated the docking site and activation mechanism. These studies inform the design of novel agonists or antagonists.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is used to generate SCTR knockout cell lines and animal models to study loss-of-function phenotypes. Knockout mice have revealed roles in circadian rhythms and food anticipatory activity [2,4]. Knock-in of tagged receptors enables imaging and trafficking studies.
How CRISPR Can Be Used to Study GO:0015055 secretin receptor activity
Knockout
CRISPR-Cas9-mediated knockout of SCTR is used to abolish secretin receptor activity and study its physiological consequences. SCTR knockout mice exhibit altered circadian rhythms and food anticipatory activity, demonstrating the receptor's role in behavior and metabolism [2,4]. Knockout cell lines are valuable for confirming receptor-specific effects in vitro.
Point Mutation
Point mutations introduced via CRISPR-Cas9 or base editing can mimic naturally occurring variants or probe structure-function relationships. For example, mutations in the SCTR extracellular domain can disrupt secretin binding, as shown by complementary mutagenesis studies. Such models help identify critical residues for receptor activation.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous SCTR locus allows real-time tracking of receptor expression and trafficking. This approach has been used to study receptor internalization and desensitization. Knock-in models also enable tissue-specific expression studies.
Overexpression
Overexpression of SCTR in heterologous cells or transgenic animals enhances secretin responsiveness and can amplify downstream signaling. This is useful for biochemical assays and for studying receptor pharmacology. Overexpression models have been used to characterize agonist potency and efficacy.
How EDITGENE Supports secretin receptor activity Research
Researchers studying secretin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, physiology, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for secretin receptor activity research.
Frequently Asked Questions About secretin receptor activity
What is secretin receptor activity?
Secretin receptor activity (GO:0015055) is the molecular function of binding to the hormone secretin and initiating a change in cell activity, primarily through Gs-mediated cAMP signaling [1,6].
What genes are involved in secretin receptor activity?
The primary gene is SCTR, which encodes the secretin receptor. Other involved genes include GNAS, ADCY1, PRKACA, and ARRB1/2 [6,8].
What is the GO ID for secretin receptor activity?
The Gene Ontology ID for secretin receptor activity is GO:0015055.
How is secretin receptor activity measured?
It is measured using radioligand binding assays, cAMP quantification, and mutagenesis studies [1,6,7].
What diseases are associated with secretin receptor activity?
Dysregulation is linked to gastrinomas, circadian rhythm disorders, and pancreatic insufficiency [5,2,1].
What are secretin receptor knockout mice used for?
They are used to study circadian rhythms, food anticipatory activity, and metabolic regulation [2,4].
What is the structure of the secretin receptor?
It is a class B G protein-coupled receptor with a large extracellular N-terminal domain that binds secretin [6,8].
How does secretin receptor signaling work?
Secretin binding activates Gs, which stimulates adenylyl cyclase to produce cAMP, leading to PKA activation and cellular responses [1,6].
Can secretin receptor activity be targeted therapeutically?
Yes, small-molecule agonists and peptide analogs are being developed for therapeutic applications [3,7].
What research methods are used to study secretin receptor activity?
Common methods include CRISPR knockout, site-directed mutagenesis, cAMP assays, and radioligand binding [1,2,7].
Conclusion
Secretin receptor activity (GO:0015055) is a critical molecular function that mediates the diverse physiological effects of secretin, from gastrointestinal secretion to circadian regulation. Its dysregulation is implicated in gastrinomas and metabolic disorders, making it a valuable target for research and therapeutic development. By leveraging CRISPR-based models and advanced pharmacological tools, researchers can further unravel the mechanisms and disease relevance of this receptor.
References
- 1. Gespach C et al.. 1986. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.. Peptides 7 Suppl 1:155-63 PMID: 3018694
- 2. Sugiyama M et al.. 2022. Secretin receptor-deficient mice exhibit robust food anticipatory activity.. Neurosci Lett 772:136462 PMID: 35051436
- 3. Ardecky R et al.. 2024. Structure-activity relationships of thiadiazole agonists of the human secretin receptor.. SLAS Discov 29(6):100176 PMID: 39122117
- 4. Sugiyama M et al.. 2020. Secretin receptor-deficient mice exhibit altered circadian rhythm in wheel-running activity.. Neurosci Lett 722:134814 PMID: 32027952
- 5. Long SH et al.. 2007. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.. J Clin Endocrinol Metab 92(11):4394-402 PMID: 17711922
- 6. Siu FK et al.. 2006. Signaling mechanisms of secretin receptor.. Regul Pept 137(1-2):95-104 PMID: 16930743
- 7. Milburn JE et al.. 2022. Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor.. Mol Pharmacol 101(6):400-407 PMID: 35351821
- 8. Dong M et al.. 2002. Molecular pharmacology of the secretin receptor.. Recept Channels 8(3-4):189-200 PMID: 12529936
